PNC Financial Services Group’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-116
| Closed | -$2K | – | 4912 |
|
|
2022
Q3 | $2K | Hold |
116
| – | – | ﹤0.01% | 4237 |
|
|
2022
Q2 | $0 | Hold |
116
| – | – | ﹤0.01% | 4838 |
|
|
2022
Q1 | $2K | Hold |
116
| – | – | ﹤0.01% | 4265 |
|
|
2021
Q4 | $0 | Hold |
116
| – | – | ﹤0.01% | 4697 |
|
|
2021
Q3 | $2K | Hold |
116
| – | – | ﹤0.01% | 4163 |
|
|
2021
Q2 | $2K | Hold |
116
| – | – | ﹤0.01% | 4074 |
|
|
2021
Q1 | $2K | Hold |
116
| – | – | ﹤0.01% | 3990 |
|
|
2020
Q4 | $2K | Hold |
116
| – | – | ﹤0.01% | 3872 |
|
|
2020
Q3 | $2K | Hold |
116
| – | – | ﹤0.01% | 3835 |
|
|
2020
Q2 | $2K | Sell |
116
-38
| -25% | -$655 | ﹤0.01% | 3813 |
|
|
2020
Q1 | $2K | Sell |
154
-50
| -25% | -$649 | ﹤0.01% | 3771 |
|
|
2019
Q4 | $5K | Buy |
204
+160
| +364% | +$3.92K | ﹤0.01% | 3675 |
|
|
2019
Q3 | $0 | Buy |
44
+6
| +16% | – | ﹤0.01% | 4155 |
|
|
2019
Q2 | $2K | Hold |
38
| – | – | ﹤0.01% | 3900 |
|
|
2019
Q1 | $2K | Hold |
38
| – | – | ﹤0.01% | 3904 |
|
|
2018
Q4 | $2K | Hold |
38
| – | – | ﹤0.01% | 3888 |
|
|
2018
Q3 | $2K | Hold |
38
| – | – | ﹤0.01% | 3985 |
|
|
2018
Q2 | $2K | Hold |
38
| – | – | ﹤0.01% | 4009 |
|
|
2018
Q1 | $2K | Buy |
38
+16
| +73% | +$842 | ﹤0.01% | 4072 |
|
|
2017
Q4 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 4034 |
|
|
2016
Q1 | – | Sell |
-51
| Closed | -$1K | – | 4600 |
|
|
2015
Q4 | $1K | Sell |
51
-2,544
| -98% | -$49.9K | ﹤0.01% | 4376 |
|
|
2015
Q3 | $46K | Buy |
2,595
+2,451
| +1,702% | +$43.4K | ﹤0.01% | 2915 |
|
|
2015
Q2 | $3K | Buy |
+144
| New | +$3K | ﹤0.01% | 4301 |
|
|
2014
Q3 | – | Sell |
-500
| Closed | -$12K | – | 4067 |
|
|
2014
Q2 | $12K | Buy |
+500
| New | +$12K | ﹤0.01% | 3101 |
|